Product Information
GUAIFENESIN ER 600 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.2840 per EA under NDC 70010019905. Its NADAC has been published 210 times since Sep 28, 2022.
FDA first approved this application on May 8, 2020.
Strength
600 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010019905
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA213420FDA Approved
5/8/2020
On Market Since
8/19/2022
Pharmacological Classes
Price Statistics
The NADAC for GUAIFENESIN ER 600 MG TABLET has been published 210 times since Sep 28, 2022, and over the history we have for it it has declined 20.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2840 per EA |
|---|---|
| All-time high | $0.3993 (Dec 11, 2024) |
| All-time low | $0.2812 (Oct 18, 2023) |
| 52-week high | $0.3211 |
| 52-week low | $0.2840 |
| Median price | $0.3233 |
| Average price | $0.3230 |
| Largest weekly change | +24.7% (Nov 20, 2024) |
| Weeks tracked | 210 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the GUAIFENESIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Granules Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
GUAIFENESIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GUAIFENESIN ER 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GUAIFENESIN ER 600 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.2840 per EA (NDC 70010019905), effective Sep 30, 2026.
How has the price of GUAIFENESIN ER 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GUAIFENESIN ER 600 MG TABLET has declined 20.0%. It has been tracked across 210 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for GUAIFENESIN ER 600 MG TABLET?
Since Sep 28, 2022, the NADAC for GUAIFENESIN ER 600 MG TABLET has ranged from a low of $0.2812 (Oct 18, 2023) to a high of $0.3993 (Dec 11, 2024), with a median of $0.3233 per EA.
Are there cheaper alternatives to GUAIFENESIN ER 600 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of GUAIFENESIN ER 600 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GUAIFENESIN ER 600 MG TABLET?
GUAIFENESIN ER 600 MG TABLET (NDC 70010019905) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.